Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Single-Center, Randomized Controlled Clinical Study on N-Acetyl-L-Cysteine Promoting Hematopoietic Recovery in Patients With Newly Diagnosed Low/Intermediate-Risk Acute Myeloid Leukemia After Complete Remission

NCT07869342 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

NCT NCT07869342
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07869342 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Single-Center, Randomized Controlled Clinical Study on N-Acetyl-L-Cysteine Promoting Hematopoietic Recovery in Patients With Newly Diagnosed Low/Intermediate-Risk Acute Myeloid Leukemia After Complete Remission
Lead sponsor
Peking University People's Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 31, 2026
Completion date
December 31, 2029
Enrollment
180 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia, adult